Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METOCLOPRAMIDE Cause Left ventricular dysfunction? 45 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Left ventricular dysfunction have been filed in association with METOCLOPRAMIDE (metoclopramide hydrochloride). This represents 0.4% of all adverse event reports for METOCLOPRAMIDE.

45
Reports of Left ventricular dysfunction with METOCLOPRAMIDE
0.4%
of all METOCLOPRAMIDE reports
14
Deaths
23
Hospitalizations

How Dangerous Is Left ventricular dysfunction From METOCLOPRAMIDE?

Of the 45 reports, 14 (31.1%) resulted in death, 23 (51.1%) required hospitalization, and 5 (11.1%) were considered life-threatening.

Is Left ventricular dysfunction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METOCLOPRAMIDE. However, 45 reports have been filed with the FAERS database.

What Other Side Effects Does METOCLOPRAMIDE Cause?

Nausea (1,080) Drug ineffective (927) Off label use (926) Drug hypersensitivity (751) Vomiting (672) Dyspnoea (525) Headache (499) Diarrhoea (481) Hypersensitivity (473) Tardive dyskinesia (465)

What Other Drugs Cause Left ventricular dysfunction?

DOXORUBICIN (430) CYCLOPHOSPHAMIDE (426) TRASTUZUMAB (401) CLOZAPINE (231) SACUBITRIL\VALSARTAN (231) BISOPROLOL (225) PERTUZUMAB (207) RITUXIMAB (202) DOCETAXEL (199) VINCRISTINE (193)

Which METOCLOPRAMIDE Alternatives Have Lower Left ventricular dysfunction Risk?

METOCLOPRAMIDE vs METOLAZONE METOCLOPRAMIDE vs METOPIMAZINE METOCLOPRAMIDE vs METOPROLOL METOCLOPRAMIDE vs METRELEPTIN METOCLOPRAMIDE vs METRONIDAZOLE

Related Pages

METOCLOPRAMIDE Full Profile All Left ventricular dysfunction Reports All Drugs Causing Left ventricular dysfunction METOCLOPRAMIDE Demographics